Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 08-2012 | 06-2012 | 05-2012 | 03-2012 | 02-2012 | |
| Cost of Goods | N/A | 4,595 | N/A | 3,478 | N/A |
| Gross Profit | N/A | -4,595 | N/A | -3,478 | N/A |
| Operating Expenses | 4 | 740 | 4 | 559 | 0 |
| Operating Income | -4 | -4,740 | -4 | -3,559 | N/A |
| Interest Expense | 0 | 27 | 0 | 17 | 0 |
| Other Income | 0 | 6 | 0 | 4 | 0 |
| Pre-tax Income | -4 | -4,760 | -4 | -3,572 | 0 |
| Net Income Continuous | -4 | -4,760 | -4 | -3,572 | N/A |
| Net Income | $-4 | $-4,760 | $-4 | $-3,572 | $N/A |
| EPS Basic Total Ops | -0.03 | -1.55 | -0.03 | -1.43 | N/A |
| EPS Basic Continuous Ops | -0.03 | -1.55 | -0.03 | -1.43 | N/A |
| EPS Diluted Total Ops | -0.03 | -1.55 | -0.03 | -1.43 | N/A |
| EPS Diluted Continuous Ops | -0.03 | -1.55 | -0.03 | -1.43 | N/A |
| EBITDA(a) | $-4 | $-4,702 | $-4 | $-3,558 | $N/A |